CN112690272B - 一种低温保存液及其保存方法 - Google Patents
一种低温保存液及其保存方法 Download PDFInfo
- Publication number
- CN112690272B CN112690272B CN202110061458.8A CN202110061458A CN112690272B CN 112690272 B CN112690272 B CN 112690272B CN 202110061458 A CN202110061458 A CN 202110061458A CN 112690272 B CN112690272 B CN 112690272B
- Authority
- CN
- China
- Prior art keywords
- low
- organoid
- preservation
- temperature
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003761 preservation solution Substances 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims abstract description 37
- 238000004321 preservation Methods 0.000 title claims abstract description 20
- 210000002220 organoid Anatomy 0.000 claims abstract description 93
- 238000005138 cryopreservation Methods 0.000 claims abstract description 29
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000007995 HEPES buffer Substances 0.000 claims abstract description 16
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims abstract description 12
- 239000002609 medium Substances 0.000 claims abstract description 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 7
- 229960005322 streptomycin Drugs 0.000 claims abstract description 6
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 44
- 239000000243 solution Substances 0.000 claims description 24
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims description 22
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims description 22
- 229940104230 thymidine Drugs 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000012574 advanced DMEM Substances 0.000 claims description 2
- 239000006481 glucose medium Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 230000010261 cell growth Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 7
- 238000011084 recovery Methods 0.000 abstract description 6
- 210000004027 cell Anatomy 0.000 description 30
- 230000012010 growth Effects 0.000 description 19
- 108010082117 matrigel Proteins 0.000 description 10
- 238000003860 storage Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 235000011089 carbon dioxide Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 3
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 230000004656 cell transport Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002631 hypothermal effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- -1 24-well plate Substances 0.000 description 1
- CMVMLPDUAGUTOC-FPBFVHJESA-N 39024-57-2 Chemical compound C([C@H]1C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)NCC(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(N)=O)CCN1C(=O)CNC(=O)[C@@H]1CCC(=O)N1 CMVMLPDUAGUTOC-FPBFVHJESA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- 102100028412 Fibroblast growth factor 10 Human genes 0.000 description 1
- 101000917237 Homo sapiens Fibroblast growth factor 10 Proteins 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 102100022762 R-spondin-1 Human genes 0.000 description 1
- 101710110302 R-spondin-1 Proteins 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002984 plastic foam Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
成分 | 来源 | 型号 | 浓度 |
Advanced DEME/F12 | Life Technologies | 12634-010 | 1X |
Glutamax | Life Technologies | 35050061 | 1X |
HEPES | Life Technologies | 15630-056 | 10mM |
Penicillin-streptomycin | Life Technologies | 15140-122 | 1X |
B27 | Life Technologies | 12587-010 | 1X |
N2 | Life Technologies | 17502-048 | 1X |
N-乙酰-半胱氨酸 | Sigma-Aldrich | A9165 | 1mM |
Nicotinamide | Sigma-Aldrich | N0636 | 10mM |
[Leu15]-gastrin I human | Sigma-Aldrich | G9145 | 10nM |
EGF | Peprotech | AF-100-15 | 50ng/ml |
FGF10 | Peprotech | 100-26 | 100ng/ml |
HGF | Peprotech | 100-39 | 25ng/ml |
Forskolin | SelleckChem | S2449 | 10μM |
A83-01 | sigma-Aldrich | SML0788 | 5μM |
R-spondin-1 | Peprotech | 120-38 | 500ng/ml |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110061458.8A CN112690272B (zh) | 2021-01-18 | 2021-01-18 | 一种低温保存液及其保存方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110061458.8A CN112690272B (zh) | 2021-01-18 | 2021-01-18 | 一种低温保存液及其保存方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112690272A CN112690272A (zh) | 2021-04-23 |
CN112690272B true CN112690272B (zh) | 2022-08-02 |
Family
ID=75515500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110061458.8A Active CN112690272B (zh) | 2021-01-18 | 2021-01-18 | 一种低温保存液及其保存方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112690272B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113287599B (zh) * | 2021-04-30 | 2022-04-19 | 创芯国际生物科技(广州)有限公司 | 一种冻存液组合物、冻存液及类器官冻存方法 |
CN114391535B (zh) * | 2022-01-19 | 2024-02-02 | 宋伟 | 用于培养类器官的样本保存液 |
CN114946837B (zh) * | 2022-06-14 | 2023-03-21 | 福建瑞庚生物科技有限公司 | 一种类器官培养用组织保存液及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201721820D0 (en) * | 2017-12-22 | 2018-02-07 | Asymptote Ltd | Method and system relating to cooling conditions for a biological sample |
CN108396010A (zh) * | 2017-02-06 | 2018-08-14 | 王琼 | 一种结直肠癌类器官的体外培养方法 |
CN111500540A (zh) * | 2020-04-14 | 2020-08-07 | 扈晖 | 一种乳腺癌类器官培养试剂盒 |
CN111808816A (zh) * | 2019-04-11 | 2020-10-23 | 北京基石生命科技有限公司 | 一种用于培养胃癌实体瘤原代细胞的培养基 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795711A (en) * | 1996-04-04 | 1998-08-18 | Circe Biomedical, Inc. | Cryopreserved hepatocytes and high viability and metabolic activity |
CN100549025C (zh) * | 2007-05-11 | 2009-10-14 | 梁铁 | 一种胸腺五肽与匹多莫德的生成物七肽及合成方法 |
CN102228016B (zh) * | 2011-04-18 | 2012-07-18 | 上海安集协康生物技术有限公司 | 一种神经干细胞冻存复苏的方法 |
CN110934132A (zh) * | 2019-12-30 | 2020-03-31 | 苏州君欣生物科技有限公司 | 一种无血清无dmso细胞冻存液及其制备方法 |
-
2021
- 2021-01-18 CN CN202110061458.8A patent/CN112690272B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108396010A (zh) * | 2017-02-06 | 2018-08-14 | 王琼 | 一种结直肠癌类器官的体外培养方法 |
GB201721820D0 (en) * | 2017-12-22 | 2018-02-07 | Asymptote Ltd | Method and system relating to cooling conditions for a biological sample |
CN111808816A (zh) * | 2019-04-11 | 2020-10-23 | 北京基石生命科技有限公司 | 一种用于培养胃癌实体瘤原代细胞的培养基 |
CN111500540A (zh) * | 2020-04-14 | 2020-08-07 | 扈晖 | 一种乳腺癌类器官培养试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN112690272A (zh) | 2021-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112690272B (zh) | 一种低温保存液及其保存方法 | |
CN112680398B (zh) | 用于可室温保存类器官的培养基及维持类器官生长活性的方法 | |
CN108207930B (zh) | 一种鸡尾酒式冷冻保护剂及其应用 | |
Chen et al. | A novel alternative to cryopreservation for the short-term storage of stem cells for use in cell therapy using alginate encapsulation | |
WO2020165152A1 (en) | Cryopreservation of stem cells | |
CN111789105B (zh) | 一种氨基酸类冷冻保存液在干细胞冻存中的应用 | |
CN108990964A (zh) | 细胞冻存液 | |
US6610531B1 (en) | Viable dried bacteria produced by drying in the presence of trehalose and divalent cation | |
EP3454653A1 (en) | Cryopreservation medium and method to prevent recrystallization | |
CN112868642B (zh) | 一种t淋巴细胞冻存液 | |
RU2577996C2 (ru) | Способ консервации биоматериала | |
CN110881459A (zh) | 一种人外周血单个核细胞冻存方法 | |
CN112094811B (zh) | 一种car-t细胞的复苏方法 | |
CN114891744A (zh) | 一种冷冻脐带血nk细胞体外扩增方法 | |
Brown et al. | Preservation of mammalian cells in a chemically defined medium and dimethylsulfoxide | |
CN113498779B (zh) | 一种运输细胞的试剂及方法 | |
Ekpo et al. | Strategies in developing dimethyl sulfoxide (DMSO)-free cryopreservation protocols for biotherapeutics | |
WO2017101587A1 (zh) | 巨核祖细胞冻存液及其应用 | |
CN102140433A (zh) | 一种细胞冻存方法 | |
CN114990053B (zh) | 一种贴壁动物细胞的规模化低温保存方法 | |
CN113462636B (zh) | 一种表皮干细胞向肝脏细胞分化的改进方法 | |
CN117050933B (zh) | 一种干细胞培养基及其应用方法 | |
CN115606581B (zh) | 干细胞冻存液及冻存方法 | |
CN114568424B (zh) | 一种脂肪间充质干细胞保存用添加剂及其应用 | |
CN211469141U (zh) | Ccfc试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231024 Address after: Room 393, building a, Zhongdan Ecological Life Science Industrial Park Phase I, No. 3-1, xinjinhu Road, Jiangbei new area, Nanjing, Jiangsu 210000 Patentee after: Nanjing Aorui Pharmaceutical Co.,Ltd. Address before: 330000 floors 1-2 of plant 10, Zhongxing Nanchang Software Industrial Park, No. 688, aixihu North Road, Nanchang high tech Industrial Development Zone, Nanchang City, Jiangxi Province Patentee before: NANCHANG FIVE ELEMENTS BIO-TECHNOLOGY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A low-temperature preservation solution and its preservation method Granted publication date: 20220802 Pledgee: Bank of Nanjing Jiangbei District branch of Limited by Share Ltd. Pledgor: Nanjing Aorui Pharmaceutical Co.,Ltd. Registration number: Y2024980011466 |